Cell Cycle Dependent Mechanisms of Renal Hypertrophy

肾肥大的细胞周期依赖性机制

基本信息

  • 批准号:
    6845408
  • 负责人:
  • 金额:
    $ 20.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-05-15 至 2007-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Provided by applicant): Early in diabetic nephropathy glomerular mesangium and renal tubules hypertrophy. Mesangial hypertrophy is an important, perhaps reversible, step preceding glomeruloscierosis and overt nephropathy. Using unique transgenic mice overexpressing retinoblastoma protein (Rb) and mesangial cells expressing Rb from a tetracycline-confrollable promoter system, we have discovered that renal and glomerular mesangial cell hypertrophy occur with both diabetes mellitus and with over expression of hypophosphorylated Rb. Preliminary data has shown that when Rh is over expressed, neither kidneys nor mesangial cells hypertrophy further in diabetic conditions. Our hypothesis to explain these observations is that excess glucose results in specific, cyclin-dependent phosphorylation of Rb protein during early Gi phase, and that Rb is involved distally in a pathway of glomerular mesangial cell hypertrophy. To test this hypothesis, three Specific Aims are proposed: (1) Determine whether renal and glomerular hypertrophy caused by diabetes mellitus in vivo and mesangial cell hypertrophy caused by high glucose concentrations ex vivo are dependent on activation of specific C1 phase cyclin-cdk complexes and specific phosphorylations of Rb protein. (2) Determine how high glucose regulates cdk4-cyclin Dl activity and Rb phosphorylation in mesangial cells by examining patterns of gene regulation including transcription of the cyclin D1 gene itself and of events controlled by relevant transcription factors including AP-1. (3) Test the requirement for Cl cyclin dependent kinase activation and specific cdk4-dependent phosphorylations of Rb protein for diabetic renal hypertrophy in vivo and mesangial cell hypertrophy in culture. Transgenic mice with strategic phosphorylation sites in Rb inactivated by site-directed mutagenesis will be generated and the effects of type 1 diabetes mellitus will be examined in them. Primary mesangial cells will also be cultured from the mice and more detailed studies on hypertrophy and GI cell cycle regulation by cdks and Rb conducted in vitro.
描述(由申请人提供):早期糖尿病肾病肾小球

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL J RILEY其他文献

DANIEL J RILEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL J RILEY', 18)}}的其他基金

Nek1 Protein Kinase and Polycystic Kidney Disease
Nek1 蛋白激酶与多囊肾病
  • 批准号:
    7508961
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
  • 批准号:
    7017009
  • 财政年份:
    2002
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
  • 批准号:
    6729104
  • 财政年份:
    2002
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
  • 批准号:
    6623538
  • 财政年份:
    2002
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
  • 批准号:
    6466738
  • 财政年份:
    2002
  • 资助金额:
    $ 20.1万
  • 项目类别:

相似海外基金

Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission
研究泛素化调节的细胞周期事件支撑疟疾传播
  • 批准号:
    MR/Y013174/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
  • 批准号:
    MR/Y01264X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Research Grant
Conference: FASEB Yeast Chromosome and Cell Cycle Conference 2024
会议:2024 年 FASEB 酵母染色体和细胞周期会议
  • 批准号:
    2403471
  • 财政年份:
    2024
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Standard Grant
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
  • 批准号:
    MR/X023087/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Fellowship
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
  • 批准号:
    10656861
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
  • 批准号:
    10714634
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell cycle control of cell polarity and fate in epidermal morphogenesis
表皮形态发生中细胞极性和命运的细胞周期控制
  • 批准号:
    10608036
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cell cycle-dependent dynein adaptor switching
细胞周期依赖性动力蛋白适配器转换
  • 批准号:
    23KF0285
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Cell cycle control of adipogenesis
脂肪生成的细胞周期控制
  • 批准号:
    10668721
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
Regulation of Cell Cycle progression by the nuclear envelope
核膜对细胞周期进程的调节
  • 批准号:
    10659597
  • 财政年份:
    2023
  • 资助金额:
    $ 20.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了